Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Not yet recruiting × HER2-positive Breast Cancer × Clear all

Phase

Phase 2 5 Phase NA 2 Phase 3 2 Phase 2/3 1

Status

Unknown 1 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 8 Stomach Neoplasms 7 Neoplasm Metastasis 5 Carcinoma, Hepatocellular 5 Breast Neoplasms 5 Rectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Recurrence 3 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Multiple Myeloma 3 Leukemia, Myeloid, Acute 3 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Nasopharyngeal Carcinoma 2 Biliary Tract Neoplasms 2 Triple Negative Breast Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thyroid Cancer, Papillary 1 Thymoma 1 Thymic epithelial tumor 1 Squamous NSCLC 1 Squamous Cell Non-small Cell Lung Cancer 1 Squamous Cell Carcinoma of Head and Neck 1 Prostate CA 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Polycystic Ovary Syndrome 1 Peritoneal Neoplasms 1 Parathyroid Neoplasms 1 Older Patients 1

Interventions

tucatinib 1 Trastuzumab 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07413939 2026-03-10

BREnnA

Hoffmann-La Roche

Phase 2/3 Not yet recruiting

HER2-positive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡